Apr 23, 2019 - Prescription drug sales, the future of Hulu, and more.
Apr 30, 2019 - There's a clear and present danger to many healthcare stocks that's more serious than anything ever before. Here's what you need to know.
May 17, 2019 - FDA grants approval for line extensions of Lilly (LLY), Pfizer (PFE) and Roche (RHHBY)/AbbVie's (ABBV) cancer drugs
May 20, 2019 - AbbVie's (ABBV) phase III study on Depatux-M, an investigational candidate for newly diagnosed glioblastoma, fails to show survival benefit in patients receiving Depatux-M.
May 24, 2019 - The index suffered a difficult week as investors braced for a protracted U.S.-China trade war.
May 28, 2019 - And the analyst really likes one in particular.
May 29, 2019 - Allergan's (AGN) sNDA for Vraylar gets the FDA approval for the treatment of adult patients with major depressive episodes related to bipolar I disorder.
Jun 07, 2019 - Pharma bigwigs present data from cancer studies at ASCO. Lilly's (LLY) CGRP Emgality gets FDA approval for episodic cluster headache in adults.
Jun 14, 2019 - Key developments of the week include Merck's (MRK) deal to buy Tilos Therapeutics and FDA approval for Roche's (RHHBY) polatuzumab vedotin and Merck's Keytruda.
Jun 14, 2019 - Dassault's acquisition of Medidata (MDSO) to close by 2019-end.